File(s) under permanent embargo
Balanced efficacy, safety, and tolerability recommendations for the clinical management of bipolar disorder
journal contribution
posted on 2012-05-01, 00:00 authored by G Malhi, D Bargh, R McIntyre, M Gitlin, M Frye, M Bauer, Michael BerkMichael BerkObjective: To provide practical and clinically meaningful treatment recommendations that amalgamate clinical experience and research findings for each phase of bipolar disorder.
Methods: A comprehensive search of the literature was undertaken using electronic database search engines (Medline, PubMed, Cochrane reviews) using key words (e.g., bipolar depression, mania, treatment). All relevant randomised controlled trials were examined, along with review papers, meta-analyses, and book chapters known to the authors. In addition, the recommendations from accompanying papers in this supplement have been distilled and captured in the form of summary boxes. The findings, in conjunction with the clinical experience of international researchers and clinicians who are practiced in treating mood disorders, formed the basis of the treatment recommendations within this paper.
Results: Balancing clinical experience with evidence informed and lead to the development of practical clinical recommendations that emphasise the importance of safety and tolerability alongside efficacy in the clinical management of bipolar disorder.
Conclusions: The current paper summarises the treatment recommendations relating to each phase of bipolar disorder while providing additional, evidence-based, practical insights. Medication-related side effects and monitoring strategies highlight the importance of safety and tolerability considerations, which, along with efficacy information, should be given equal merit.
Methods: A comprehensive search of the literature was undertaken using electronic database search engines (Medline, PubMed, Cochrane reviews) using key words (e.g., bipolar depression, mania, treatment). All relevant randomised controlled trials were examined, along with review papers, meta-analyses, and book chapters known to the authors. In addition, the recommendations from accompanying papers in this supplement have been distilled and captured in the form of summary boxes. The findings, in conjunction with the clinical experience of international researchers and clinicians who are practiced in treating mood disorders, formed the basis of the treatment recommendations within this paper.
Results: Balancing clinical experience with evidence informed and lead to the development of practical clinical recommendations that emphasise the importance of safety and tolerability alongside efficacy in the clinical management of bipolar disorder.
Conclusions: The current paper summarises the treatment recommendations relating to each phase of bipolar disorder while providing additional, evidence-based, practical insights. Medication-related side effects and monitoring strategies highlight the importance of safety and tolerability considerations, which, along with efficacy information, should be given equal merit.
History
Journal
Bipolar disorders supplementVolume
14Issue
Supplement 2Season
Special issue : Balanced efficacy, safety, and tolerability recommendations for the clinical management of bipolar disorderPagination
1 - 21Publisher
Wiley - Blackwell PublishingLocation
Malden, Mass.Publisher DOI
ISSN
1399-2406eISSN
1600-5511Language
engPublication classification
C1 Refereed article in a scholarly journalCopyright notice
2012, John Wiley and Sons A/SUsage metrics
Read the peer-reviewed publication
Categories
Keywords
acute treatmentbipolar disorderevidence-based reviewguidelinesmaintenance treatmenttreatmentScience & TechnologyLife Sciences & BiomedicineClinical NeurologyNeurosciencesPsychiatryNeurosciences & NeurologyPLACEBO-CONTROLLED TRIALLONG-TERM TREATMENTOLANZAPINE-FLUOXETINE COMBINATIONLITHIUM MAINTENANCE TREATMENTTREATMENTS CANMAT GUIDELINESCONTROLLED 18-MONTH TRIALWEEKLY SYMPTOMATIC STATUSDEPRESSIVE MIXED-STATEOPEN-LABEL EXTENSIONDOUBLE-BLIND